Drug Database
Back to search

Netherlands· NL-e03b609a2669

Ilumira 37 GBq/ml radiofarmaceutische uitgangsstof, oplossing

A other therapeutic radiopharmaceuticals product containing lutetium [177lu]trichloride, registered in Netherlands by Shine Europe B.V.. The same ATC class is registered in 8 of our 19 countries.

ATC V10X

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedIlumira 37 GBq/ml radiofarmaceutische…ATCV10XREGISTER NO.NL-e03b609a2669PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about lutetium [177lu]trichlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Lutetium [177lu]trichloride is registered in 8 of 19 countries.

Countries holding a registration under ATC V10X (other therapeutic radiopharmaceuticals), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 5 of them publish a price we can compare per daily dose
Search lutetium [177lu]trichloride products by name

Lutetium [177lu]trichloride · ATC V10X

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
LUTETIUM [177Lu]TRICHLORIDE
Manufacturer
Shine Europe B.V.
Country
Netherlands (NL)
ATC code
V10X
ATC class
OTHER THERAPEUTIC RADIOPHARMACEUTICALS
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/26/2018

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under V10X

Other therapeutic radiopharmaceuticals, as other registers publish it.

All lutetium [177lu]trichloride products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/440b68fb-4706-4bc7-ae69-0251fcc20778
GET /v1/drugs/440b68fb-4706-4bc7-ae69-0251fcc20778?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Radiofarmaceutische uitgangsstof",
  "route": "Standaardterm niet beschikbaar",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/ilumira-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Other Therapeutic Radiopharmaceuticals",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp134669",
  "excipients": [
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "LUTETIUM [177Lu]TRICHLORIDE"
  ],
  "leaflet_url": null,
  "authorised_at": "2026/03/26",
  "procedure_number": "EMEA/H/C/006596",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/26/2018",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about lutetium [177lu]trichloride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console